News | Enterprise Imaging | November 19, 2020

Infinitt Highlights Enterprise Imaging Platform with Extensive Line of Diagnostic Capabilities at RSNA 2020

Infinitt has added a Digital Pathology Solution and a Radiation Therapy PACS to its product offerings

Infinitt has added a Digital Pathology Solution and a Radiation Therapy PACS to its product offerings

November 19, 2020 — Infinitt North America, a single-source provider of enterprise imaging solutions for healthcare, will be participating in RSNA’s virtual meeting, November 29- December 5, 2020, and invites attendees to connect and learn about Infinitt’s diagnostic viewers for radiology, mammography, cardiology, pathology, oncology, ophthalmology, and dental imaging. Infinitt offers Infinitt Healthcare Platform (VNA), an enterprise viewer, encounters-based imaging workflow (EBIW), enterprise search capability for research and clinical decision support, and a multi-disciplinary workflow with patient-centered integrated worklist.

Infinitt solutions are offered as cloud-based solutions, on-premises turnkey solutions including hardware and software with/without managed services, and software only solutions using the customer’s VM or server environment.

Featured Products:

  • Infinitt Healthcare Platform (IHP), a standards-based VNA that manages DICOM and non-DICOM data on a powerful database. Includes routing, ILM, system monitoring and seamless integration with your EMR for content sharing and display.
  • Infinitt PACS 7.0 for Radiology, a fast and powerful diagnostic viewer built to leverage Artificial Intelligence (AI) to enhance reading workflow, to support diagnostic accuracy and to enrich the user experience. New features include a highly configurable Dynamic Worklist, thumbnail images of patient priors, navigation shortcuts, embedded image fusion, and auto-registration of images. The mammography viewer, Infinitt Mammo PACS, provides a full toolset for breast imaging, with newly updated features tailored to mammography screening. These include layout modes and sequences, a mammography keypad, higher image quality and easier-to-navigate UI. The mammography viewer supports breast tomosynthesis with specialized features such as mammography tomosynthesis CAD SR, direct movement to lesions in frames, and tomo slab rendering to improve the visibility of micro- calcification. Optional modules include embedded Speech Recognition, Enterprise Search capability, dose management, business analytics and advanced communication and conferencing tools.
  • Infinitt RIS, driven from the same powerful database as Infinitt PACS, eliminating interfaces between systems and simplifying integration with EMRs and third- party billing systems. New features in Infinitt RIS are designed to eliminate time-consuming tasks in your radiology department or imaging center workflow.
  • Infinitt Advanced Visualization Platform offers seamless integration with third-party Advanced Visualization packages. This allows physicians to access post-processing and analytical tools from within the Infinitt viewer, and to save their work with a single sign-on and no disruption in reading workflow.
  • Infinitt AI Platform allows you to access a library of AI algorithms to test and/or deploy, with seamless integration into clinical workflows. Infinitt has marketing partnerships with independent AI developers Vuno, Lunit, Aidence, CureMetrix, and more.
  • Infinitt Cardiology Suite is a web-based PACS and reporting system for cardiology and vascular imaging, EKG and nuclear medicine. It integrates all your cardiovascular data into one solution, streamlining image management, analysis, reporting and submission to data registries. Infinitt Cardiology Suite can be used as a stand-alone system or become fully integrated with Infinitt PACS, consolidating data for the EHR. Sophisticated report creation with auto-population of measurements and interpretations.
  • Infinitt Digital Pathology PACS* (IDPS) enables quantitative image analysis and remote reading for primary diagnosis and multi-disciplinary review.  IDPS facilitates collaboration, research, and the application of AI. (*Pending FDA approval).
  • Infinitt RT PACS, a dedicated Radiation Therapy solution that centralizes and displays all treatment plans, dose distribution information and treatment summaries. Infinitt RT PACS creates a more collaborative and patient-centered environment, as it improves communication with referring physicians and specialists.
  • Multi-Disciplinary Platform (MDT), with patient-centered integrated worklist, enables physicians to view images and documents from all departments. One click brings up a dedicated viewer for each study. Optimized communication tools and screen sharing to support telemedicine. Integrated management and retrieval of all data required for Precision Medicine.

For more information: www.infinittna.com

Related Content

Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer

Image courtesy of UCLA Health

News | PET-CT | February 23, 2021
February 23, 2021 — A...
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | February 22, 2021
February 22, 2021 — According to an...
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in

Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from (f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications. Image courtesy of Professor Alessandro Olivo

News | Breast Imaging | February 22, 2021
February 22, 2021 — A new X-ray imaging scanne
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci
 Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS). 
News | Enterprise Imaging | February 18, 2021
February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired...
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | February 18, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (a–c) are taken from a patient with a Pilocytic Astrocytoma, (d–f) are from a patient with an Ependymoma and (g–i) were acquired from a patient with a Medulloblastoma.

Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (ac) are taken from a patient with a Pilocytic Astrocytoma, (df) are from a patient with an Ependymoma and (gi) were acquired from a patient with a Medulloblastoma. Image courtesy of Nature Research Journal

News | Pediatric Imaging | February 17, 2021
February 17, 2021 — Diffusio...
T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.

T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.

News | Magnetic Resonance Imaging (MRI) | February 17, 2021
February 17, 2021 — A new paper,...